ChemGenex Pharmaceuticals
2 clinical trials · Sponsor
◉ Watch ChemGenex Pharmaceuticals
| Record | Firm | Date |
|---|---|---|
| Pharmacokinetic (PK) Study of Homoharringtonine (Omacetaxine Mepesuccinate) Administered Subcutaneously to Patients With Advanced Solid and Hematologic Tumors (NCT00675350) | ChemGenex Pharmaceuticals | 2008-04-01 |
| Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML) (NCT00114959) | ChemGenex Pharmaceuticals | 2005-10-01 |
Track ChemGenex Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.